Symptoms


Last updated:
Total hit(s): 145
Select item(s)
Key Findings
Comments
(You can add your comments too!)
Original Article
(hover to see details)
Diarrhea and Abdominal pain were the only gastrointestinal symptoms with 5.9% prevalence each, out of 187 symptomatic cases.
33513332
(Emerg Infect Dis)
PMID
33513332
Date of Publishing: 2021 Mar
Title Epidemiology and Clinical Course of First Wave Coronavirus Disease Cases, Faroe Islands
Author(s) nameKristiansen MF, Heimustovu BH et al.
Journal Emerg Infect Dis
Impact factor
6.81
Citation count: 1


Cough (44.4%) was one of the prevalent respiratory symptom among 166 symptomatic cases, followed by sore throat (30%).
33513332
(Emerg Infect Dis)
PMID
33513332
Date of Publishing: 2021 Mar
Title Epidemiology and Clinical Course of First Wave Coronavirus Disease Cases, Faroe Islands
Author(s) nameKristiansen MF, Heimustovu BH et al.
Journal Emerg Infect Dis
Impact factor
6.81
Citation count: 1


88.8% were symptomatic, of which Fever (63%) and Headache (47.6%) were the major symptoms in general whereas only 11.2% were asymptomatic.
33513332
(Emerg Infect Dis)
PMID
33513332
Date of Publishing: 2021 Mar
Title Epidemiology and Clinical Course of First Wave Coronavirus Disease Cases, Faroe Islands
Author(s) nameKristiansen MF, Heimustovu BH et al.
Journal Emerg Infect Dis
Impact factor
6.81
Citation count: 1


This research had focused on evaluating the presence of symptoms of Anxiety Disorder in adolescents with hearing loss during the COVID-19 pandemic. Among the deaf participants,18 were pre-lingually deaf and 5 were post-lingually deaf. Of the hard of hearing participants, 23 used hearing aids
33618708
(BMC Psychiatry)
PMID
33618708
Date of Publishing: 2021 Feb 22
Title Symptoms of anxiety disorders in Iranian adolescents with hearing loss during the COVID-19 pandemic
Author(s) name Ariapooran S, Khezeli M.
Journal BMC Psychiatry
Impact factor
2.86
Citation count: 1


100 Patients were surveyed post-discharge and the symptoms reported by them were recorded and divided into two categories based on whether or not they were in the ICU during hospitalisation. Data analysis was carried out using Microsoft Excel with descriptive statistics. Mobility, personal care, usual activities, pain and anxiety/depression were addressed using the EQ5D5L Version for Interviewer Administration
32729939
(J Med Virol)
PMID
32729939
Date of Publishing: 2021 Feb
Title Postdischarge symptoms and rehabilitation needs in survivors of COVID19 infection: A crosssectional evaluation
Author(s) nameHalpin SJ, McIvor C et al.
Journal J Med Virol
Impact factor
2.07
Citation count: 12


A cross sectional study including 105 patients with documented clinical recovery and virological clearance to evaluate the prevalence of anxiety or/and depression. 1. The patients underwent medical examination one to three months after virological clearance.
32841387
(J Med Virol)
PMID
32841387
Date of Publishing: 2021 Feb
Title Anxiety and depression symptoms after virological clearance of COVID19: a crosssectional study in Milan, Italy
Author(s) nameTomasoni D, Bai F et al.
Journal J Med Virol
Impact factor
2.07
Citation count: 2


All the 3 clusters share Headache, Myalgia, Sore throat as common symptoms based on Tandem clustering analysis. 87,253 (56%) belonged to the common cluster and was reported the most frequent cluster. Symptomatic cases (20%) were more in contact with COVID-19 cases than presymptomatic (9%). Common cluster was represented in Blue in the Panel B of given Symptomatic profiling graph link.
33434668
(Int J Infect Dis)
PMID
33434668
Date of Publishing: 2021 Jan 9
Title Epidemiology of COVID-19 in Mexico: Symptomatic profiles andpresymptomatic people
Author(s) nameFernández-Rojas MA, Luna-Ruiz Esparza MA et al.
Journal Int J Infect Dis
Impact factor
3.42
Citation count: 1


Respiratory symptoms cluster was the second most frequent cluster with 34% occurence rate (52,827). Family members with COVID-19 were more frequently symptomatic (13%) than presymptomatic (6%). Respiratory cluster was represented in Gold in the given Symptomatic profiling graph in Panel B.
33434668
(Int J Infect Dis)
PMID
33434668
Date of Publishing: 2021 Jan 9
Title Epidemiology of COVID-19 in Mexico: Symptomatic profiles and presymptomatic people
Author(s) nameFernández-Rojas MA, Luna-Ruiz Esparza MA et al.
Journal Int J Infect Dis
Impact factor
3.42
Citation count: 1


Gastrointestinal symptoms cluster was the third frequent cluster with 10% occurrence rate (16,518). Non-communicable diseases (Hypertension, Diabetes, Obesity) were more prevalent in symptomatic than presymptomatic cases. Presymptomatic carriers were observed in 13% (25,520) of the SARS-CoV-2 cases with no symptoms on test day and previous days. More common among older adults (31%) than children (26%).
33434668
(Int J Infect Dis)
PMID
33434668
Date of Publishing: 2021 Jan 9
Title Epidemiology of COVID-19 in Mexico: Symptomatic profiles and presymptomatic people
Author(s) nameFernández-Rojas MA, Luna-Ruiz Esparza MA et al.
Journal Int J Infect Dis
Impact factor
3.42
Citation count: 1


Fever was the major symptom in 25 patients among 36 symptomatic cases, whereas Chest pain, Headache, Fatigue, Myalgia and Delirium were all minor symptoms.
33509318
(Epidemiol Infect)
PMID
33509318
Date of Publishing: 2021 Jan 29
Title Epidemiology of COVID-19 in Northern Ireland, 26 February 2020-26 April 2020
Author(s) namePett J, McAleavey P et al.
Journal Epidemiol Infect
Impact factor
2.01
Citation count: 1


Cough was the most prevalent respiratory symptom and was reported in 24 of 36 symptomatic patients.
33509318
(Epidemiol Infect)
PMID
33509318
Date of Publishing: 2021 Jan 29
Title Epidemiology of COVID-19 in Northern Ireland, 26 February 2020-26 April 2020
Author(s) namePett J, McAleavey P et al.
Journal Epidemiol Infect
Impact factor
2.01
Citation count: 1


A case study in Mexico, of a SARS-CoV-2 positive patient presenting hiccups as the only symptom. Probable cause of the patient's symptoms was phrenic nerve inflammation secondary to COVID-19 pneumonia.
33472577
(Int J Emerg Med)
PMID
33472577
Date of Publishing: 2021 Jan 20
Title Hiccups and psychosis: two atypical presentations of COVID-19
Author(s) name Alvarez-Cisneros T, Lara-Reyes A, Sansón-Tinoco S.
Journal Int J Emerg Med
Citation count 1


A case study in Mexico, of a SARS-CoV-2 positive patient with an acute episode of pychosis as the only symptom. Lab results revealed Hypokalemia K 3.3, elevation of hepatic enzymes -aspartate aminotransferase 53U/L, alanine aminotransferase 69U/L, indirect hyperbilirubinemia and elevated ferritin levels (595ng/mL).
33472577
(Int J Emerg Med)
PMID
33472577
Date of Publishing: 2021 Jan 20
Title Hiccups and psychosis: two atypical presentations of COVID-19
Author(s) name Alvarez-Cisneros T, Lara-Reyes A, Sansón-Tinoco S.
Journal Int J Emerg Med
Citation count 1


This study characterises the prevalence, onset and nature of musculoskeletal complaints in COVID-19 patients and explores their clinical significance. Statistics were performed using SPSS Statistics for Windows, Version 26.0 (IBM Corp, Armonk, New York).Clinical characteristics were compared between patients with and without musculoskeletal symptoms, and between patients in the different musculoskeletal groups using the Mann-Whitney U test, Fishers exact test and one-way ANOVA as appropriate
33476761
(Int J Infect Dis)
PMID
33476761
Date of Publishing: 2021 Jan 18
Title Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms
Author(s) nameHoong CWS, Amin MNME et al.
Journal Int J Infect Dis
Impact factor
3.42
Citation count: 1


The study was conducted in a virtual outpatient COVID-19 clinic with aims to describe symptom profile and clinical outcomes.
33469566
(SN Compr Clin Med)
PMID
33469566
Date of Publishing: 2021 Jan 14
Title Symptoms and Clinical Outcomes of Coronavirus Disease 2019 in the Outpatient Setting
Author(s) nameKnight D, Downes K et al.
Journal SN Compr Clin Med
Impact factor
Cant find
Citation count: 1


103 COVID-19 patients were screened for 13 subjective neurological symptoms along with anxiety and depression as a major focus. Depression and anxiety are frequent symptoms in patients with SARS-CoV2 infection needing careful medical evaluation and follow-up. Moreover, counteracting these neuropsychological symptoms can improve the reaction to the infection and can need of specific treatments in order to improve the possibility of rehabilitation and recovery.
32987349
(J Affect Disord)
PMID
32987349
Date of Publishing: 2021 Jan 1
Title Depressive and anxiety symptoms in patients with SARS-CoV2 infection
Author(s) nameLiguori C, Pierantozzi M et al.
Journal J Affect Disord
Impact factor
4.17
Citation count: 1


103 COVID-19 patients were screened for 13 subjective neurological symptoms along with anxiety and depression as a major focus. Depression and anxiety are frequent symptoms in patients with SARS-CoV2 infection needing careful medical evaluation and follow-up. Moreover, counteracting these neuropsychological symptoms can improve the reaction to the infection and can need of specific treatments in order to improve the possibility of rehabilitation and recovery.
32987349
(J Affect Disord)
PMID
32987349
Date of Publishing: 2021 Jan 1
Title Depressive and anxiety symptoms in patients with SARS-CoV2 infection
Author(s) nameLiguori C, Pierantozzi M et al.
Journal J Affect Disord
Impact factor
4.17
Citation count: 1


A study among clinical healthcare workers to determine rates of anxiety and depression and the factors associated with their prevalence. The questionnaire included Perceived Stress Scale-10 (PSS-10), Generalized Anxiety Disorder 7-Item Scale (GAD-7) and Patient Health Questionnaire-9 (PHQ-9). Factors associated with anxiety and depression symptoms were estimated by logistic regression analysis.The database was constructed by using EpiDate3.1 and analyzed by SPSS 25.0.
32961409
(J Affect Disord)
PMID
32961409
Date of Publishing: 2021 Jan 1
Title Anxiety and depression symptoms of medical staff under COVID-19 epidemic in China
Author(s) nameLiu Y, Chen H et al.
Journal J Affect Disord
Impact factor
4.17
Citation count: 4


A multinational cross-sectiolnal survey to determine prevelance of anxiety symptoms and associated risk and protective factors during the COVID-19 pandemic. COVID-19 related education in LMICs can help decrease stigma and can enghance mental health in communities.
33035760
(J Psychiatr Res)
PMID
33035760
Date of Publishing: 2021 Jan
Title Frequency and correlates of anxiety symptoms during the COVID-19 pandemic in low- and middle-income countries: A multinational study
Author(s) nameCénat JM, Dalexis RD et al.
Journal J Psychiatr Res
Impact factor
4.23
Citation count: 3


A study of patients discharged from a single centre in France,conducted to monitor the persistence of symptoms post-discharge, through a telephonic questionnaire. mMRC-modified Medical Research Council grade 2 (Walks slower than people of the same age because of dyspnoea or has to stop for breath when walking at own pace)
32853602
(J Infect)
PMID
32853602
Date of Publishing: 2020 Dec
Title Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19
Author(s) nameGarrigues E, Janvier P et al.
Journal J Infect
Impact factor
5.1
Citation count: 12


A case study of a 52 year old man with SARS-CoV-2 infection who developed vesicular skin eruptions and subsequent GI symptons but not any typical symptoms associated with COVID-19. The patient did not have any respiratory symptoms
33471878
(Cutis)
PMID
33471878
Date of Publishing: 2020 Dec
Title Skin eruption and gastrointestinal symptoms as presentation of COVID-19
Author(s) name Chu S, Christensen LF, Vidmar D.
Journal Cutis
Impact factor
0.47
Citation count: 1


Analysis of 11 COVID-19 positive patients with recurrent viral symptoms or viral re-infection. The fact that patients could experience re-activation of a long-lasting virus carriage or might be re-infected, as well as potential long-term effects of drugs or diseases that hamper the immune response, constitutes a substantial point of vigilance for the management of the pandemic at the individual and collective levels.
32619697
(J Infect)
PMID
32619697
Date of Publishing: 2020 Nov
Title Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?
Author(s) nameGousseff M, Penot P et al.
Journal J Infect
Impact factor
5.1
Citation count: 43


34.3% of liver transplant recipients with COVID-19 presented Dyspnea as a respiratory symptom.
32891405
(Transplant Proc)
PMID
32891405
Date of Publishing: 2020 Nov
Title Clinical Presentation, Treatment, and Mortality Rate in Liver Transplant Recipients With Coronavirus Disease 2019: A Systematic Review and Quantitative Analysis
Author(s) nameFraser J, Mousley J et al.
Journal Transplant Proc
Impact factor
0.95
Citation count: 4


2701 volunteers were surveyed to assess perceived stress, sleep quality, insomnia, depression symptoms, and anxiety, using standard questionnaires.
33102641
(Neurobiol Stress)
PMID
33102641
Date of Publishing: 2020 Nov
Title Gender-related time course of sleep disturbances and psychological symptoms during the COVID-19 lockdown: a longitudinal study on the Italian population
Author(s) nameSalfi F, Lauriola M et al.
Journal Neurobiol Stress
Citation count 1


67% of liver transplant recipients with COVID-19 presented Fever as a general symptom.
32891405
(Transplant Proc)
PMID
32891405
Date of Publishing: 2020 Nov
Title Clinical Presentation, Treatment, and Mortality Rate in Liver Transplant Recipients With Coronavirus Disease 2019: A Systematic Review and Quantitative Analysis
Author(s) nameFraser J, Mousley J et al.
Journal Transplant Proc
Impact factor
0.95
Citation count: 4